Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Multiple Endocrine Neoplasia Type 1 4Neoplasms 2Skin Neoplasms 1Rosacea 1Psoriasis 1Pregnancy Complications 1Neurologic Manifestations 1Metabolic Diseases 1Melanoma 1Endocrine System Diseases 1Diabetes Mellitus 1Dermatitis, Atopic 1Cerebrovascular Disorders 1Cardiovascular Diseases 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Eating × Clear all
NCT06234267 2025-05-23

Eat, Play, Sleep: A Text Message Approach to Promoting Health Behaviors for Cancer Survivors and Their Caregivers

University of Arizona

Phase NA Completed
44 enrolled
Tumor-Agnostic

Neoplasms

NCT03328546 2023-04-14

Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer)

Harvard School of Public Health (HSPH)

Completed
116,671 enrolled

Cardiovascular Diseases, Cerebrovascular Disorders, Diabetes Mellitus, Endocrine System Diseases, Metabolic Diseases, Neoplasms, Neurologic Manifestations, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡